共 41 条
- [34] Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study British Journal of Cancer, 2022, 126 : 969 - 969
- [35] Clinical Events After Discontinuation of -Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction A Cohort Study on the French Healthcare Databases CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2018, 11 (04):
- [40] Phase II study of pembrolizumab (pemb) plus plinabulin (plin) and docetaxel (doc) for patients (pts) with metastatic NSCLC after failure on first-line immune checkpoint inhibitor alone or combination therapy: Initial efficacy and safety results on Immune Re-sensitization ANNALS OF ONCOLOGY, 2024, 35 : S845 - S845